Literature DB >> 25983116

Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells.

Suhashini S Dhumale1, Bhargav N Waghela1, Chandramani Pathak1.   

Abstract

The receptor for advanced glycation end-products (RAGE) is a multiligand member of the immunoglobulin superfamily, which plays an important role in maintaining cellular homeostasis. It is normally expressed on immune cells, including macrophages, monocytes, dendritic cells and T cells to maintain homeostasis, but highly upregulated at sites of vascular pathology. Accumulating evidence suggest that the elevated expression of RAGE and its ligand HMGB-1 was found in various types of cancer. The accumulation of RAGE and its ligand high-mobility group box proteins-1 (HMGB1) activates complex signaling network for cell survival and evades apoptosis. Therefore, targeting the RAGE-mediated signaling could be the promising strategies for the therapeutic potential of cancer. This study was aimed to examine the biological potential of quercetin on the regulation of RAGE- and HMGB1-mediated activation of NF-κB and induction of apoptotic cell death in MCF-7 cells. Our findings demonstrate that quercetin inhibits the expression of RAGE and HMGB1 in MCF-7 cells. In addition, quercetin protects necrotic insult and augments apoptosis in MCF-7 cells. Taken together, these results suggest that quercetin plays an important role in modulating RAGE and HMGB1 signaling and induces apoptotic cell death in MCF-7 cells.
© 2015 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  HMGB1; RAGE; apoptosis; cancer; necrosis; quercetin

Mesh:

Substances:

Year:  2015        PMID: 25983116     DOI: 10.1002/iub.1379

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  13 in total

1.  Pluronic micelles encapsulated curcumin manifests apoptotic cell death and inhibits pro-inflammatory cytokines in human breast adenocarcinoma cells.

Authors:  Foram U Vaidya; Rakesh Sharma; Sofiya Shaikh; Debes Ray; Vinod K Aswal; Chandramani Pathak
Journal:  Cancer Rep (Hoboken)       Date:  2018-09-24

Review 2.  RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review.

Authors:  Gowri Palanissami; Solomon F D Paul
Journal:  Horm Cancer       Date:  2018-07-09       Impact factor: 3.869

3.  Expression of FADD and cFLIPL balances mitochondrial integrity and redox signaling to substantiate apoptotic cell death.

Authors:  Kishu Ranjan; Chandramani Pathak
Journal:  Mol Cell Biochem       Date:  2016-09-13       Impact factor: 3.396

Review 4.  The implication and potential applications of high-mobility group box 1 protein in breast cancer.

Authors:  Moonindranath Sohun; Huiling Shen
Journal:  Ann Transl Med       Date:  2016-06

Review 5.  Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression.

Authors:  Yadav Sangeeta Muthyalaiah; Bhavana Jonnalagadda; Cordelia Mano John; Sumathy Arockiasamy
Journal:  Glycoconj J       Date:  2022-01-22       Impact factor: 2.916

Review 6.  High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications.

Authors:  Han Wu; Zheng Chen; Jun Xie; Li-Na Kang; Lian Wang; Biao Xu
Journal:  Mediators Inflamm       Date:  2016-10-25       Impact factor: 4.711

Review 7.  High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.

Authors:  Shunling Yuan; Zhaoping Liu; Zhenru Xu; Jing Liu; Ji Zhang
Journal:  J Hematol Oncol       Date:  2020-07-13       Impact factor: 17.388

Review 8.  Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression.

Authors:  Ali H El-Far; Grazyna Sroga; Soad K Al Jaouni; Shaker A Mousa
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 9.  AGE-RAGE synergy influences programmed cell death signaling to promote cancer.

Authors:  Bhargav N Waghela; Foram U Vaidya; Kishu Ranjan; Abu Sufiyan Chhipa; Budhi Sagar Tiwari; Chandramani Pathak
Journal:  Mol Cell Biochem       Date:  2020-10-06       Impact factor: 3.396

10.  HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer.

Authors:  Bi-Fei Huang; Huey-En Tzeng; Po-Chun Chen; Chao-Qun Wang; Chen-Ming Su; Yan Wang; Gui-Nv Hu; Yong-Ming Zhao; Qian Wang; Chih-Hsin Tang
Journal:  Int J Med Sci       Date:  2018-03-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.